Clinical findings of hyperechoic substantia nigra in patients with Parkinson's disease

被引:1
|
作者
Fan, Yongyan [1 ,2 ]
Ma, Jianjun [1 ,2 ,3 ,4 ]
Yang, Dawei [1 ,2 ]
Li, Xiaohuan [1 ,2 ]
Liang, Keke [2 ,3 ]
She, Zonghan [1 ,2 ]
Qi, Xuelin [1 ,2 ]
Shi, Xiaoxue [1 ,2 ,3 ]
Gu, Qi [1 ,2 ,3 ]
Zheng, Jinhua [1 ,2 ,3 ]
Li, Dongsheng [1 ,2 ,3 ]
机构
[1] Zhengzhou Univ, Peoples Hosp, Dept Neurol, Zhengzhou, Peoples R China
[2] Henan Prov Peoples Hosp, Dept Neurol, Zhengzhou, Peoples R China
[3] Henan Univ, Peoples Hosp, Dept Neurol, Zhengzhou, Peoples R China
[4] Zhengzhou Univ, Peoples Hosp, Dept Neurol, Zhengzhou 450003, Peoples R China
关键词
biomarker; hyperechoic substantia nigra; iron deposition; microglial activation; Parkinson's disease; TRANSCRANIAL BRAIN SONOGRAPHY; IRON ACCUMULATION; URIC-ACID; DIFFERENTIAL-DIAGNOSIS; TASK-FORCE; HYPERECHOGENICITY; ECHOGENICITY; SENSITIVITY; SCALE; REPRODUCIBILITY;
D O I
10.1111/ejn.16308
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study aims to analyse hyperechoic substantia nigra (HSN) characteristics and the correlation of HSN with clinical features and blood biomarkers in patients with Parkinson's disease (PD). Transcranial sonography (TCS) evaluations of the substantia nigra (SN) were performed in 40 healthy controls and 71 patients with PD, including patients with SN hyperechogenicity (SN+) and those with normal SN echogenicity (SN-). Evaluation of motor and non-motor symptoms was assessed by a series of rating scales. The uricase method was used to determine serum uric acid (UA) levels, and enzyme-linked immunosorbent assay (ELISA) was used to measure plasma interleukin (IL)-1 beta levels. TCS showed 92.50% specificity and 61.97% sensitivity in differentiating PD patients from controls. The area of SN+ contralateral to the side of initial motor symptoms (SNcontra) was larger than that ipsilateral to the side of initial motor symptoms (SNipsi). The PDSN+ group had lower Argentine Hyposmia Rating Scale (AHRS) scores and UA levels than the PDSN- group. Binary logistic regression analysis revealed that AHRS scores and UA levels could be independent predictors for HSN. The larger SN echogenic area (SNL) sizes positively correlated with plasma IL-1 beta levels in PD patients with SN+. The present study provides further evidence of the potential of SN echogenicity as an imaging biomarker for PD diagnosis. PD patients with HSN have more severe non-motor symptoms of hyposmia. HSN in PD patients is related to the mechanism of abnormal iron metabolism and microglial activation. Transcranial sonography (TCS) has potential as a tool for Parkinson's disease (PD) diagnosis. Hyperechoic substantia nigra (HSN) is a stable marker during the course of PD and does not reflect disease progression. PD patients with HSN have severer non-motor symptoms of hyposmia. HSN in PD patients is related to the mechanism of abnormal iron metabolism and microglial activation. image
引用
收藏
页码:2702 / 2714
页数:13
相关论文
共 50 条
  • [41] Substantia nigra hyperechogenicity and Parkinson's disease risk in patients with essential tremor
    Sprenger, Fabienne S.
    Wurster, Isabel
    Seppi, Klaus
    Stockner, Heike
    Scherfler, Christoph
    Sojer, Martin
    Schmidauer, Christof
    Berg, Daniela
    Poewe, Werner
    MOVEMENT DISORDERS, 2016, 31 (04) : 579 - 583
  • [42] MICROGLIAL ACTIVATION BEYOND THE SUBSTANTIA NIGRA IN PARKINSON'S DISEASE
    Doorn, K.
    Lucassen, P. J.
    Bol, J. G. J.
    Drukarch, B.
    van de Berg, W. D. J.
    van Dam, A-M.
    GLIA, 2013, 61 : S166 - S167
  • [43] Proteome analysis of human substantia nigra in Parkinson's disease
    Cornelius J Werner
    Roland Heyny-von Haussen
    Gerhard Mall
    Sabine Wolf
    Proteome Science, 6
  • [44] Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease
    R. K. B. Pearce
    A. Owen
    S. Daniel
    P. Jenner
    C. D. Marsden
    Journal of Neural Transmission, 1997, 104 : 661 - 677
  • [45] Quantitative Susceptibility Mapping of the Substantia Nigra in Parkinson's Disease
    Zhao, Xinxin
    An, Hedi
    Liu, Tian
    Shen, Nan
    Bo, Binshi
    Zhang, Zhuwei
    Weng, Pengfei
    Chen, Meining
    Pei, Mengchao
    Wang, Yi
    Huang, Dongya
    Li, Jianqi
    APPLIED MAGNETIC RESONANCE, 2017, 48 (06) : 533 - 544
  • [46] Substantia nigra hyperechogenicity in Parkinson's disease motor phenotypes
    Toomsoo, T.
    Pool, A. -H.
    Liepelt-Scarfone, I.
    Kadastik-Eerme, L.
    Asser, T.
    Berg, D.
    Taba, P.
    MOVEMENT DISORDERS, 2016, 31 : S409 - S409
  • [47] Proteome analysis of human substantia nigra in Parkinson's disease
    Werner, C. J.
    Heyny-von Haussen, R.
    Mall, G.
    Wolf, S.
    MOVEMENT DISORDERS, 2007, 22 : S201 - S201
  • [48] Proteasomal function is impaired in substantia nigra in Parkinson's disease
    McNaught, KSP
    Jenner, P
    NEUROSCIENCE LETTERS, 2001, 297 (03) : 191 - 194
  • [49] α-synuclein expression in substantia nigra and cortex in Parkinson's disease
    Neystat, M
    Lynch, T
    Przedborski, S
    Kholodilov, N
    Rzhetskaya, M
    Burke, RE
    MOVEMENT DISORDERS, 1999, 14 (03) : 417 - 422
  • [50] The substantia nigra echogenity in Parkinson's disease -: A pilot study
    Ressner, P.
    Skoloudik, D.
    Kanovsky, P.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2006, 69 (05) : 376 - 379